← Top stories
Market move▼ Bearish for Apollo Hospitals
Hospital stocks sell-off a buying opportunity or a risk? Here is what analysts advice
The brief
- The Supreme Court flagged a case where drugs costing 2,700 to retailers were billed at 27,000 to patients
- Hospital pricing scrutiny may pressure hospital operators, including Apollo Hospitals
- Market wrap: Kotak Mahindra Bank, InterGlobe, Apollo Hospital, Max Healthcare top gainers and losers on Nifty and Sensex on Wednesday
- Stocks making the biggest moves midday: Apollo Hospitals, Max Health, Rail Vikas, and more
- Apollo Hospitals, Yatharth, others fall up to 6% on SC's 'corporate hospitals don't spare anyone' remark
- Technical analysts pick Paytm, DRL as buys; Marico, Amber Ent, Apollo Hospitals, Bosch as sells
- Apollo Hospital Share Price Live Updates: Apollo Hospital's Stock Price Declines Below 100-Day SMA
Hospital drug markups and pricing regulation concerns
The Supreme Court questioned hospital markups on cancer drugs, including a case where a medicine costing ₹2,700 to retailers was billed at ₹27,000 to patients, and urged a probe. Hospital stocks fell sharply, erasing $2.6 billion in value, as investors weighed possible medicine price curbs.
Thursday, 1 October
- Hospital stocks sell-off a buying opportunity or a risk? Here is what analysts advice